Characterization of a novel, non-peptidyl antagonist of the human glucagon receptor
about
Structure of the human glucagon class B G-protein-coupled receptorControl of blood glucose in the absence of hepatic glucose production during prolonged fasting in mice: induction of renal and intestinal gluconeogenesis by glucagonLandmark studies on the glucagon subfamily of GPCRs: from small molecule modulators to a crystal structureInhibitory Mechanism of an Allosteric Antibody Targeting the Glucagon ReceptorTransmembrane signal transduction by peptide hormones via family B G protein-coupled receptorsChemogenomic analysis of G-protein coupled receptors and their ligands deciphers locks and keys governing diverse aspects of signallingThe Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsGlucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeoverGlucagon signaling modulates sweet taste responsiveness.Insights into the structure of class B GPCRs.Recent Progress in the Use of Glucagon and Glucagon Receptor Antago-nists in the Treatment of Diabetes MellitusSmall-molecule agonists for the glucagon-like peptide 1 receptor.Glucagon as a target for the treatment of Type 2 diabetes.Allosteric modulators of class B G-protein-coupled receptorsAllosteric Modulation of G Protein Coupled Receptors by Cytoplasmic, Transmembrane and Extracellular Ligands.A survey of small molecule glucagon receptor antagonists from recent patents (2006 - 2010).Stable liquid glucagon formulations for rescue treatment and bi-hormonal closed-loop pancreasStructure of Class B GPCRs: new horizons for drug discovery.Novel parathyroid hormone (PTH) antagonists that bind to the juxtamembrane portion of the PTH/PTH-related protein receptor.Identification of the first nonpeptidergic inverse agonist for a constitutively active viral-encoded G protein-coupled receptor.Biological and functional characteristics of a novel low-molecular weight antagonist of glucose-dependent insulinotropic polypeptide receptor, SKL-14959, in vitro and in vivo.What is the potential of G protein-coupled receptor [corrected] allosteric sites in drug design?Paracrine Interactions within the Pancreatic Islet Determine the Glycemic Set Point.Structure-Based Discovery of Allosteric Modulators of Two Related Class B G-Protein-Coupled Receptors
P2860
Q24601619-F3D0B507-25EE-4416-B2D9-E8DDF216A9C9Q24624586-7FEE2EEA-855B-464F-BE46-5C0E87AAD6ECQ26798049-9A0AB447-BEEB-47D5-92EC-2D6C8AD0F391Q27680518-4E0AE975-64D5-4C83-9BCC-41907D278DA5Q28082755-89E23358-6F5A-4897-9A66-F4F7B4110F7FQ28477082-A2FDD304-15CD-40FB-BFC0-3AC69F20428AQ30486707-83F62EA1-A083-4E4A-923E-E8D9C37E1DE9Q34244209-BA2BC6BF-F89A-4B00-9402-A0E017C88B0EQ34378866-AB5D4CBE-E73D-4AF3-B303-1CC3DB19563DQ34393487-41CB1EB8-6E1E-4520-9B2C-8D862DCACF4AQ35062439-101E5AEE-B81F-4449-BA37-FB17574279EDQ35612392-649AD84B-CAD6-4399-9ED5-F355AE35513EQ36158732-BDBD7C21-C101-4F0C-907B-2EB2917FAA66Q37131132-D2038A3E-97B4-4AD4-AB4B-A84F7B2F1113Q37140580-0CD5C840-BA2C-4EA8-B99C-9CAD1F3D3439Q37884060-86189C41-65B0-4669-ADCF-1222C1444B4FQ38042847-B517EB9A-468F-42E3-85B3-929DF8163AD6Q38195892-FE9074CA-6EBB-4C55-8033-83CDE302DACCQ40490382-CA1EBA6D-8341-429E-AF52-FF52D7ACC008Q44232692-00DC2B98-9C6E-4DD2-9E4C-B1CE01708C4AQ44660849-63749B95-2A20-4240-AAE0-31927BAAFE82Q48875964-9C2C41DB-24B4-44DA-A98B-7D6C34E5AD8AQ52728181-5309C24A-17B3-4185-9194-A978C2B24408Q56991997-0A2F759D-0C91-42FD-9FDB-D4F453D3D74D
P2860
Characterization of a novel, non-peptidyl antagonist of the human glucagon receptor
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Characterization of a novel, non-peptidyl antagonist of the human glucagon receptor
@ast
Characterization of a novel, non-peptidyl antagonist of the human glucagon receptor
@en
Characterization of a novel, non-peptidyl antagonist of the human glucagon receptor
@nl
type
label
Characterization of a novel, non-peptidyl antagonist of the human glucagon receptor
@ast
Characterization of a novel, non-peptidyl antagonist of the human glucagon receptor
@en
Characterization of a novel, non-peptidyl antagonist of the human glucagon receptor
@nl
prefLabel
Characterization of a novel, non-peptidyl antagonist of the human glucagon receptor
@ast
Characterization of a novel, non-peptidyl antagonist of the human glucagon receptor
@en
Characterization of a novel, non-peptidyl antagonist of the human glucagon receptor
@nl
P2093
P356
P1476
Characterization of a novel, non-peptidyl antagonist of the human glucagon receptor
@en
P2093
D Louizides
G G Chicchi
M A Cascieri
P P Vicario
S E de Laszlo
S J Sadowski
P304
P356
10.1074/JBC.274.13.8694
P407
P577
1999-03-26T00:00:00Z